Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000821549 | SCV000962308 | uncertain significance | GLUT1 deficiency syndrome 1, autosomal recessive | 2018-10-23 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine with phenylalanine at codon 215 of the SLC2A1 protein (p.Leu215Phe). The leucine residue is highly conserved and there is a small physicochemical difference between leucine and phenylalanine. This variant is not present in population databases (ExAC no frequency). This variant has been observed in a family affected with early onset absence epilepsy and paroxysmal exertional dyskinesia (PMID: 23106342). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001664443 | SCV001875333 | likely pathogenic | not provided | 2022-05-17 | criteria provided, single submitter | clinical testing | Observed in multiple patients with epilepsy or dystonia without intellectual disability (Arsov et al., 2012; Zaman et al., 2018); Published functional studies demonstrate a damaging effect (functionally abnormal glucose uptake in Xenopus oocytes compared to wildtype) (Zaman et al., 2018); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 30588498, 23106342) |